Clinical trial
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
NCT00475280 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Completed
Key facts
| NCT number | NCT00475280 |
|---|---|
| Title | "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients |
| Official title | "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients. GIMEMA Protocol LAL1104. EudraCT Code 2005-002156-17 |
| Acronym | LAL1104 |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoblastic, Acute |
| Intervention type | Procedure |
| Interventions | Geriatric assessment adapted therapy, Stem cells autotransplantation |
| Enrollment | 102 |
| Start date | Nov 1, 2007 |
| Primary completion | Dec 1, 2016 |
| Completion | Jan 28, 2020 |
| First posted | May 21, 2007 |
| Last update posted | Oct 12, 2022 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: